Failures (cause and time) of radiotherapy in oral cancer

F. Volterrani, S. Barni, F. Chiesa, C. Uslenghi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The results of a retrospective clinical evaluation concerning 434 cases of oral carcinomas treated with radiotherapy from January 1959 to December 1967 are presented. The analysis of the results obtained shows that radiotherapy alone may offer a reasonable possibility of success in limited lesions (68.3% 5-year survival of Stage I patients). In more advanced local cases, and especially those with regional adenopathies, radiotherapy alone cannot consistently control the disease for a long period of time; 5-year survival from the onset of treatment was respectively 36.5% and 24.5% for Stage II and III cases. Moreover, if contralateral or bilateral metastatic adenopathies or fixed lymph nodes are present, the prognosis becomes dramatic (2.6% 5-year survival of Stage IV patients). Among the irradiation techniques currently available, curietherapy (interstitial applications or surface molds) presumably offers the best possibility of success, since the observed failures, both overall and stage by stage, are inferior. Radiotherapy alone may generally be of proven efficacy if the local or locoregional extension is limited. In more advanced cases a combined surgery-chemotherapy treatment method is recommended. The criteria for a combined therapeutic approach for these tumors are also discussed.

Original languageEnglish
Pages (from-to)193-203
Number of pages11
JournalTumori
Volume64
Issue number2
Publication statusPublished - 1978

Fingerprint

Mouth Neoplasms
Radiotherapy
Survival
Brachytherapy
Fungi
Therapeutics
Lymph Nodes
Carcinoma
Drug Therapy
Neoplasms
Lymphadenopathy

ASJC Scopus subject areas

  • Cancer Research

Cite this

Volterrani, F., Barni, S., Chiesa, F., & Uslenghi, C. (1978). Failures (cause and time) of radiotherapy in oral cancer. Tumori, 64(2), 193-203.

Failures (cause and time) of radiotherapy in oral cancer. / Volterrani, F.; Barni, S.; Chiesa, F.; Uslenghi, C.

In: Tumori, Vol. 64, No. 2, 1978, p. 193-203.

Research output: Contribution to journalArticle

Volterrani, F, Barni, S, Chiesa, F & Uslenghi, C 1978, 'Failures (cause and time) of radiotherapy in oral cancer', Tumori, vol. 64, no. 2, pp. 193-203.
Volterrani F, Barni S, Chiesa F, Uslenghi C. Failures (cause and time) of radiotherapy in oral cancer. Tumori. 1978;64(2):193-203.
Volterrani, F. ; Barni, S. ; Chiesa, F. ; Uslenghi, C. / Failures (cause and time) of radiotherapy in oral cancer. In: Tumori. 1978 ; Vol. 64, No. 2. pp. 193-203.
@article{c05a92e567ca4adc8b49c83bf64e867e,
title = "Failures (cause and time) of radiotherapy in oral cancer",
abstract = "The results of a retrospective clinical evaluation concerning 434 cases of oral carcinomas treated with radiotherapy from January 1959 to December 1967 are presented. The analysis of the results obtained shows that radiotherapy alone may offer a reasonable possibility of success in limited lesions (68.3{\%} 5-year survival of Stage I patients). In more advanced local cases, and especially those with regional adenopathies, radiotherapy alone cannot consistently control the disease for a long period of time; 5-year survival from the onset of treatment was respectively 36.5{\%} and 24.5{\%} for Stage II and III cases. Moreover, if contralateral or bilateral metastatic adenopathies or fixed lymph nodes are present, the prognosis becomes dramatic (2.6{\%} 5-year survival of Stage IV patients). Among the irradiation techniques currently available, curietherapy (interstitial applications or surface molds) presumably offers the best possibility of success, since the observed failures, both overall and stage by stage, are inferior. Radiotherapy alone may generally be of proven efficacy if the local or locoregional extension is limited. In more advanced cases a combined surgery-chemotherapy treatment method is recommended. The criteria for a combined therapeutic approach for these tumors are also discussed.",
author = "F. Volterrani and S. Barni and F. Chiesa and C. Uslenghi",
year = "1978",
language = "English",
volume = "64",
pages = "193--203",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Failures (cause and time) of radiotherapy in oral cancer

AU - Volterrani, F.

AU - Barni, S.

AU - Chiesa, F.

AU - Uslenghi, C.

PY - 1978

Y1 - 1978

N2 - The results of a retrospective clinical evaluation concerning 434 cases of oral carcinomas treated with radiotherapy from January 1959 to December 1967 are presented. The analysis of the results obtained shows that radiotherapy alone may offer a reasonable possibility of success in limited lesions (68.3% 5-year survival of Stage I patients). In more advanced local cases, and especially those with regional adenopathies, radiotherapy alone cannot consistently control the disease for a long period of time; 5-year survival from the onset of treatment was respectively 36.5% and 24.5% for Stage II and III cases. Moreover, if contralateral or bilateral metastatic adenopathies or fixed lymph nodes are present, the prognosis becomes dramatic (2.6% 5-year survival of Stage IV patients). Among the irradiation techniques currently available, curietherapy (interstitial applications or surface molds) presumably offers the best possibility of success, since the observed failures, both overall and stage by stage, are inferior. Radiotherapy alone may generally be of proven efficacy if the local or locoregional extension is limited. In more advanced cases a combined surgery-chemotherapy treatment method is recommended. The criteria for a combined therapeutic approach for these tumors are also discussed.

AB - The results of a retrospective clinical evaluation concerning 434 cases of oral carcinomas treated with radiotherapy from January 1959 to December 1967 are presented. The analysis of the results obtained shows that radiotherapy alone may offer a reasonable possibility of success in limited lesions (68.3% 5-year survival of Stage I patients). In more advanced local cases, and especially those with regional adenopathies, radiotherapy alone cannot consistently control the disease for a long period of time; 5-year survival from the onset of treatment was respectively 36.5% and 24.5% for Stage II and III cases. Moreover, if contralateral or bilateral metastatic adenopathies or fixed lymph nodes are present, the prognosis becomes dramatic (2.6% 5-year survival of Stage IV patients). Among the irradiation techniques currently available, curietherapy (interstitial applications or surface molds) presumably offers the best possibility of success, since the observed failures, both overall and stage by stage, are inferior. Radiotherapy alone may generally be of proven efficacy if the local or locoregional extension is limited. In more advanced cases a combined surgery-chemotherapy treatment method is recommended. The criteria for a combined therapeutic approach for these tumors are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0018092490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018092490&partnerID=8YFLogxK

M3 - Article

VL - 64

SP - 193

EP - 203

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 2

ER -